182 related articles for article (PubMed ID: 16299503)
1. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10.
Laurent P; Becker JA; Valverde O; Ledent C; de Kerchove d'Exaerde A; Schiffmann SN; Maldonado R; Vassart G; Parmentier M
Nat Neurosci; 2005 Dec; 8(12):1735-41. PubMed ID: 16299503
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor.
Langmead CJ; Szekeres PG; Chambers JK; Ratcliffe SJ; Jones DN; Hirst WD; Price GW; Herdon HJ
Br J Pharmacol; 2000 Oct; 131(4):683-8. PubMed ID: 11030716
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
4. Blockade of PrRP attenuates MPTP-induced toxicity in mice.
Sun B; Mochiduki A; Nakamura K; Yokoyama K; Adachi S; Fujiwara K; Matsumoto H; Inoue K
Peptides; 2009 Jul; 30(7):1267-75. PubMed ID: 19540425
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor.
Ma L; MacTavish D; Simonin F; Bourguignon JJ; Watanabe T; Jhamandas JH
Eur J Neurosci; 2009 Oct; 30(8):1585-93. PubMed ID: 19821834
[TBL] [Abstract][Full Text] [Related]
6. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
[TBL] [Abstract][Full Text] [Related]
7. The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice.
Gu W; Geddes BJ; Zhang C; Foley KP; Stricker-Krongrad A
J Mol Neurosci; 2004; 22(1-2):93-103. PubMed ID: 14742914
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
[TBL] [Abstract][Full Text] [Related]
9. Alternative role for prolactin-releasing peptide in the regulation of food intake.
Lawrence CB; Celsi F; Brennand J; Luckman SM
Nat Neurosci; 2000 Jul; 3(7):645-6. PubMed ID: 10862694
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide FF, prolactin-releasing peptide, and the receptor UHR1/GPR10 genes during embryogenesis in the rat.
Nieminen ML; Nystedt J; Panula P
Dev Dyn; 2003 Mar; 226(3):561-9. PubMed ID: 12619141
[TBL] [Abstract][Full Text] [Related]
11. Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.
Swinnen E; Boussemaere M; Denef C
J Neuroendocrinol; 2005 Jun; 17(6):379-86. PubMed ID: 15929743
[TBL] [Abstract][Full Text] [Related]
12. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
13. Lack of neuropeptide Y attenuates the somatic signs of opiate withdrawal.
Olson VG; Griner NB; Heusner CL; Palmiter RD
Synapse; 2006 Dec; 60(7):553-6. PubMed ID: 16952158
[TBL] [Abstract][Full Text] [Related]
14. Expression of brain prolactin releasing peptide (PrRP) changes in the estrous cycle of female rats.
Feng Y; Zhao H; An XF; Ma SL; Chen BY
Neurosci Lett; 2007 May; 419(1):38-42. PubMed ID: 17475403
[TBL] [Abstract][Full Text] [Related]
15. Increased stress-induced analgesia in mice lacking the proneuropeptide convertase PC2.
Croissandeau G; Wahnon F; Yashpal K; Seidah NG; Coderre TJ; Chrétien M; Mbikay M
Neurosci Lett; 2006 Oct; 406(1-2):71-5. PubMed ID: 16905251
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-releasing Peptide mediates cholecystokinin-induced satiety in mice.
Bechtold DA; Luckman SM
Endocrinology; 2006 Oct; 147(10):4723-9. PubMed ID: 16794001
[TBL] [Abstract][Full Text] [Related]
17. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
[TBL] [Abstract][Full Text] [Related]
18. Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms.
Kalliomäki ML; Pertovaara A; Brandt A; Wei H; Pietilä P; Kalmari J; Xu M; Kalso E; Panula P
Neuropharmacology; 2004 Mar; 46(3):412-24. PubMed ID: 14975697
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
20. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
